CTGF公司
肌成纤维细胞
肺纤维化
转化生长因子
纤维化
生长因子
结缔组织
细胞生物学
成纤维细胞
特发性肺纤维化
间充质干细胞
博莱霉素
免疫学
分泌物
化学
癌症研究
生物
细胞培养
病理
医学
肺
内分泌学
内科学
受体
化疗
生物化学
遗传学
作者
Qian Yin,Hai‐Yan Nan,Wen‐Hu Zhang,Lin‐Feng Yan,Guangbin Cui,Xiaofeng Huang,Jing‐Guo Wei
摘要
Abstract Accumulation and activation of myofibroblasts are the hallmark of progressive pulmonary fibrosis, and the resident fibroblasts are the major source of myofibroblasts. However, the key factors involved in the transformation of fibroblasts are unknown. Pulmonary microvascular endothelial cells (PMVECs), major effector cells against pathogenesis in early stages of the disease, can secrete cytokines to induce the differentiation of mesenchymal cells. We speculated that PMVECs could secrete pro‐fibrotic cytokines and promote the transformation of fibroblasts into myofibroblasts. Accordingly, we established a co‐culture system with PMVECs and fibroblasts to examine the specific transformation and collagen synthesis of the co‐cultured fibroblasts by FACS and Western blot, prior to and after treatment with neutralizing antibodies against transforming growth factor‐beta1 (TGF‐β1) and connective tissue growth factor (CTGF). We also analyzed expression of TGF‐β1 and CTGF in PMVECs. The synthesis and secretion of TGF‐β1 and CTGF protein were up‐regulated in PMVECs isolated from bleomycin (BLM)‐treated rats, most prominently at 7 days post‐instillation. We showed that the PMVECs isolated from BLM‐induced rats could induce the transformation of normal fibroblasts and their secretion of collagen I, which was inhibited by both neutralizing anti‐TGF‐β1 and anti‐CTGF antibodies. Therefore, up‐regulation of TGF‐β1 and CTGF in PMVECs plays an important role in activation, transformation, and collagen synthesis of fibroblasts; in particular, these effects in PMVECs are likely to be the key factors for activation and stimulation of static fibroblasts in lung interstitium in early stages of pulmonary fibrosis disease. J. Cell. Physiol. 226: 2091–2102, 2011. © 2010 Wiley‐Liss, Inc.
科研通智能强力驱动
Strongly Powered by AbleSci AI